Development and implementation of guidelines for the management of depression: a systematic review

作者：Yena L. Lee, Elisa Brietzke, Bing Qing Cao, Yan Chen, Outi Linnaranta, Rodrigo Barbachan Mansur, Paulina Cortes, Markus Kösters, Amna Majeed, Jocelyn K. Tamura, Leanna M.W. Lui, Maj Vinberg, Jaakko Keinänen, Steve R Kisely, Sadiq Naveed, Corrado Barbui, Gary Parker, Mayowa Ojo Owolabi, Daisuke Nishi, JungGoo Lee, Manit Srisurapanont, Hartej Gill, Lan Guo, Vicent Balanzá‐Martínez, Timo Partonen, Willem A. Nolen, Jae-Hon Lee, Ji Hwan Kim, Niels Henrik Chavannes, Tatjana Ewais, Beatriz Atienza-Carbonell, Anna V Silven, Naonori Yasuma, Artyom Gil, Andrey V. Novikov, Cameron James Lacey, Anke Versluis, Sofia von Malortie, Lai Fong Chan, Ahmed Waqas, Marianna Purgato, Jiska Joëlle Aardoom, Josefina T Ly-Uson, Kang Sim, Maria Tuineag, Rianne van der Kleij, Sanne van Luenen, Sirijit Suttajit, Tomáš Hájek, Yu Wei Lee, Richard Porter, Mohammad T. Alsuwaidan, Joshua Daniel Rosenblat, Arun V Ravindran, Raymond Wing Moon Lam, Roger S. McIntyre, on behalf of the Global Alliance for Chronic Diseases (GACD) Mental Health Guidelines Working Group · 发表于：Bulletin of the World Health Organization · 年份：2020 · DOI：10.2471/blt.20.251405 · 被引用次数：46 · 研究领域：Clinical practice guidelines implementation、Health Policy Implementation Science、Mental Health and Patient Involvement

OBJECTIVE: To evaluate the development and implementation of clinical practice guidelines for the management of depression globally. METHODS: We conducted a systematic review of existing guidelines for the management of depression in adults with major depressive or bipolar disorder. For each identified guideline, we assessed compliance with measures of guideline development quality (such as transparency in guideline development processes and funding, multidisciplinary author group composition, systematic review of comparative efficacy research) and implementation (such as quality indicators). We compared guidelines from low- and middle-income countries with those from high-income countries. FINDINGS: We identified 82 national and 13 international clinical practice guidelines from 83 countries in 27 languages. Guideline development processes and funding sources were explicitly specified in a smaller proportion of guidelines from low- and middle-income countries (8/29; 28%) relative to high-income countries (35/58; 60%). Fewer guidelines (2/29; 7%) from low- and middle-income countries, relative to high-income countries (22/58; 38%), were authored by a multidisciplinary development group. A systematic review of comparative effectiveness was conducted in 31% (9/29) of low- and middle-income country guidelines versus 71% (41/58) of high-income country guidelines. Only 10% (3/29) of low- and middle-income country and 19% (11/58) of high-income country guidelines described plans to...